Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 12:03 AM
NCT ID: NCT05498558
Eligibility Criteria: Inclusion Criteria: 1. After tubal pregnancy treatment (including expectant therapy, medication, salpingotomy), the blood hCG value returns to normal; 2. The patient has fertility requirements; 3. The age of the patient is between 18-41 years old; 4. Regular menstruation; 5. There is no abnormality in the husband's semen examination; 6. No history of sex hormone drugs in the 3 months prior to the examination; 7. No underlying diseases such as heart, liver, kidneys and brain; 8. No history of tuberculosis; 9. Normal blood routine examination (WBC≥ 4\*109/L, HB≥100g/L, PLT≥100\*109/L); 10. Normal liver and kidney function tests; 11. Normal thyroid function; 12. The patient can withstand and receive follicle monitoring during pregnancy; 13. Negative for pregnancy test before treatment. Exclusion Criteria: 1. Cervical pregnancy, cesarean scar pregnancy, cornual pregnancy, interstitial pregnancy; 2. The age of the patient \< 18 years or \> 41 years; 3. Irregular menstruation or abnormal results of sex hormone tests during follow-up; 4. Abnormal results of the man's semen examination during the follow-up period; 5. The patient has a tendency to bleed easily; 6. History of myometriosis and endometriosis; 7. Abnormal blood routine examination or liver and kidney function; 8. History of cardiovascular diseases, including severe hypertension, severe arrhythmias, history of myocardial infarction; 9. History of hepatitis B or C infection and patient has a detectable viral load; 10. Patients with active tuberculosis; 11. History of malignant tumors; 12. Unable to regularly monitor the follicles during pregnancy; 13. Unconditional long-term follow-up;
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 41 Years
Study: NCT05498558
Study Brief:
Protocol Section: NCT05498558